TY - JOUR
T1 - The management of chronic prostatitis in men with HIV
AU - Santillo, Vincent M.
AU - Lowe, Franklin C.
PY - 2006/7
Y1 - 2006/7
N2 - Prostatitis is a common urologic diagnosis. Although treatment algorithms are available for this poorly understood entity, several adaptations must be made in order to accommodate the therapeutic needs of HIV-positive patients. The most important consideration when treating HIV-infected patients for prostatitis is their current immune status, whether they are immunocompromised or not (non-progressive disease or reconstituted with highly active antiretroviral therapy). A treatment algorithm for those with chronic bacterial prostatitis (Category II), chronic nonbacterial prostatitis (Category IIIA), and prostatodynia (Category IIIB) is presented in this article. In the HIV-positive patient population, there is a greater likelihood for atypical pathogens including fungi, tuberculosis, anaerobes, and viruses. Because the HIV-infected patient is at increased risk for the development of prostatic abscess and urosepsis than the general population, increased monitoring and evaluation and longer-term appropriately directed antimicrobial therapy are required.
AB - Prostatitis is a common urologic diagnosis. Although treatment algorithms are available for this poorly understood entity, several adaptations must be made in order to accommodate the therapeutic needs of HIV-positive patients. The most important consideration when treating HIV-infected patients for prostatitis is their current immune status, whether they are immunocompromised or not (non-progressive disease or reconstituted with highly active antiretroviral therapy). A treatment algorithm for those with chronic bacterial prostatitis (Category II), chronic nonbacterial prostatitis (Category IIIA), and prostatodynia (Category IIIB) is presented in this article. In the HIV-positive patient population, there is a greater likelihood for atypical pathogens including fungi, tuberculosis, anaerobes, and viruses. Because the HIV-infected patient is at increased risk for the development of prostatic abscess and urosepsis than the general population, increased monitoring and evaluation and longer-term appropriately directed antimicrobial therapy are required.
UR - http://www.scopus.com/inward/record.url?scp=33748741640&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33748741640&partnerID=8YFLogxK
U2 - 10.1007/s11934-996-0011-3
DO - 10.1007/s11934-996-0011-3
M3 - Review article
C2 - 16930503
AN - SCOPUS:33748741640
SN - 1527-2737
VL - 7
SP - 313
EP - 319
JO - Current urology reports
JF - Current urology reports
IS - 4
ER -